Pharmaceutical Equipment for Vial and Tablet Inspection

Pharmaceutical Equipment for Vial and Tablet Inspection Market Outlook

The global pharmaceutical equipment market for vial and tablet inspection is projected to reach approximately USD 4.5 billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period. This growth can be attributed to the increasing demand for high-quality pharmaceuticals and the stringent regulations governing drug safety and efficacy. Moreover, the rise in chronic diseases and the subsequent surge in pharmaceutical production are expected to further amplify the need for advanced inspection equipment. Additionally, the integration of cutting-edge technologies, such as machine vision and automation, is enabling manufacturers to enhance their production processes, improve accuracy, and reduce human error. The growing trend towards personalized medicine is also driving the need for specialized inspection equipment capable of handling small batch sizes and diverse product mixes.

Growth Factor of the Market

Several factors are driving the growth of the pharmaceutical equipment market for vial and tablet inspection. Firstly, the increasing investments in pharmaceutical R&D to combat the rise of complex diseases necessitate sophisticated inspection technologies to ensure product integrity. Secondly, the adoption of automation in production lines is pushing for equipment that can operate efficiently and accurately without human intervention. This trend is complemented by the regulatory push for compliance with Good Manufacturing Practices (GMP) and other quality standards that require robust inspection processes. Furthermore, the growing demand for biologics and biosimilars, which often come in vial forms, expands the market for inspection equipment specifically designed for these products. Lastly, the expansion of pharmaceutical manufacturing sectors in emerging economies is creating more opportunities for market growth, as these regions seek to modernize their facilities with advanced inspection solutions.

Key Highlights of the Market

• The global pharmaceutical equipment market for inspection is expected to witness a CAGR of 7.2% from 2025 to 2035.
• Growing regulatory pressure for drug safety and quality assurance is a significant growth driver.
• Adoption of automation and advanced technologies, such as machine vision, is transforming production processes.
• Emerging economies are increasingly investing in modern pharmaceutical manufacturing, providing growth opportunities.
• The rising prevalence of chronic diseases is driving the demand for effective pharmaceutical inspection equipment.

By Product Type

Vial Inspection Machines:

Vial inspection machines are essential in the pharmaceutical industry, primarily designed to detect defects in vials containing liquid medications or biologics. These machines utilize advanced vision systems to check for particles, glass defects, and fill levels, ensuring the integrity of the products. With the growth in the biologics sector, the demand for vial inspection is skyrocketing, as manufacturers must comply with stringent regulatory standards. The ability to inspect at high speeds without compromising accuracy has made vial inspection machines a critical component of modern pharmaceutical production lines. As the complexity of drug formulations increases, these machines have evolved to include features such as automated handling and real-time data processing, enhancing productivity and efficiency in the inspection process.

Tablet Inspection Machines:

Tablet inspection machines play a crucial role in ensuring the quality and safety of solid dosage forms. These machines are designed to identify imperfections in tablets, such as color variations, size discrepancies, and surface defects. Given the massive scale of tablet production, efficiency is vital, and these machines are equipped with high-speed capabilities to inspect thousands of tablets per minute. Moreover, with the growing trend toward personalized medicine, manufacturers require flexible inspection solutions that can adapt to various tablet sizes and formulations. The integration of artificial intelligence and machine learning into tablet inspection processes is also emerging as a major trend, allowing for improved detection rates and reduced false positives, ultimately leading to higher quality products and customer satisfaction.

Ampoule Inspection Machines:

Ampoule inspection machines are specifically designed to inspect glass ampoules filled with liquid pharmaceuticals. These machines utilize various inspection methods, such as visual, automated, and machine vision systems, to detect cracks, chips, and particles in the ampoules. As the market for injectable drugs continues to grow, driven by the rise in chronic conditions and the demand for biologics, the importance of efficient and reliable ampoule inspection has become paramount. The technology involved in these machines has advanced significantly, featuring enhanced imaging systems that provide real-time feedback, thereby ensuring that only compliant products proceed to packaging. The emphasis on patient safety and regulatory compliance further propels the demand for these specialized inspection machines.

Syringe Inspection Machines:

Syringe inspection machines are vital for ensuring the quality of pre-filled syringes. With the increasing use of injectables in treatment protocols, the need for efficient inspection solutions to identify defects such as bubbles, fill volumes, and surface irregularities is more critical than ever. These machines utilize sophisticated imaging technology to conduct thorough inspections at high speeds, thus streamlining the production process. Furthermore, the rise in biologics and biosimilars, which are often delivered via syringe, is escalating the demand for syringe inspection machines. Manufacturers are now focusing on automating these inspection processes to enhance throughput while maintaining stringent quality standards, which is essential for regulatory compliance and patient safety.

Capsule Inspection Machines:

Capsule inspection machines are designed to ensure the integrity and quality of capsules used in pharmaceutical formulations. These machines examine capsules for defects such as discoloration, size irregularities, and surface damage. Given the ongoing trend of increasing capsule-based drug formulations, the demand for these machines is on the rise, as they play a critical role in maintaining product quality. Integration with advanced technologies, such as Near-Infrared Spectroscopy (NIR) and machine vision, allows for rapid and accurate inspections, thus improving production efficiency. Additionally, with an increasing focus on patient adherence to medications, manufacturers are looking to produce visually appealing and high-quality medications, further fueling the need for robust capsule inspection solutions.

By Application

Drug Manufacturing:

Drug manufacturing is the primary application driving the demand for pharmaceutical inspection equipment. The need for stringent quality control measures throughout the manufacturing process has made inspection machines indispensable. These machines ensure that every batch produced meets the required standards of safety and efficacy, reducing the risk of defective products reaching the market. The need to comply with regulatory requirements further necessitates the use of advanced inspection technologies, allowing manufacturers to automate quality checks and minimize human error. Moreover, as the complexity of pharmaceuticals increases, manufacturers are relying on sophisticated inspection systems capable of adapting to various drug forms and sizes, ensuring the delivery of safe and effective medications to patients.

Research Laboratories:

Research laboratories are increasingly incorporating inspection equipment to maintain high standards in the development of new drug formulations. This application is critical as it involves the testing and validation of drug products before they enter mass production. The presence of pharmaceutical inspection equipment in research labs contributes to the overall reliability of laboratory results, as these machines are equipped to detect minute defects that could impact the overall efficacy of a drug. Furthermore, with the current trend towards precision medicine, research laboratories are utilizing inspection equipment that can adapt to various compounds and formulations, ensuring that all drug candidates meet the necessary quality benchmarks before progressing to clinical trials. This adaptability is vital to facilitating innovation in drug development.

Packaging:

Packaging is another essential application driving the growth of the pharmaceutical inspection equipment market. The packaging process is critical in protecting products from contamination and ensuring product integrity. Inspection machines are employed to verify that packaging meets the necessary standards and is free from defects. This is especially vital for products that will be stored for extended periods or transported over long distances. The rise of e-commerce and global distribution networks has intensified the need for reliable packaging inspection solutions, as any defect can lead to significant financial losses and jeopardize patient safety. As packaging technology evolves, so too does the need for advanced inspection systems capable of adapting to new packaging formats and materials.

By User

Pharmaceutical Companies:

Pharmaceutical companies constitute a significant user segment for inspection equipment, as they are the primary manufacturers of drugs and biologics. The need for high-quality products mandates that these companies invest heavily in inspection technologies to ensure compliance with regulatory guidelines. With the increasing complexity of drug formulations and a heightened focus on patient safety, pharmaceutical companies are adopting advanced inspection solutions that streamline their production processes. Furthermore, the competitive landscape in the pharmaceutical sector is compelling these companies to improve operational efficiencies, leading to a surge in investments in sophisticated inspection machinery that enhances throughput and maintains quality standards.

Contract Research Organizations (CROs):

Contract Research Organizations (CROs) play a crucial role in the pharmaceutical ecosystem, particularly in drug development and clinical trials. As these organizations are often responsible for conducting extensive research and testing of new pharmaceutical compounds, the demand for reliable inspection equipment is essential. CROs utilize inspection technologies to validate the quality and safety of drug formulations during various stages of research and development. The growing trend of outsourcing research and development activities to CROs is further driving the demand for inspection equipment as pharmaceutical companies seek to ensure that their products meet all necessary quality benchmarks. Additionally, the ability of CROs to leverage advanced inspection technologies can provide them with a competitive edge in the market.

By Technology

Machine Vision Systems:

Machine vision systems are revolutionizing the pharmaceutical inspection landscape by offering high-speed, accurate, and reliable inspection processes. These systems utilize cameras and advanced image processing algorithms to detect defects in vials, tablets, and other pharmaceutical products. With the integration of artificial intelligence, machine vision systems can adapt to various inspection criteria and significantly reduce false positives, leading to enhanced product quality. As manufacturers strive for increased automation to improve efficiency, the adoption of machine vision systems is becoming a standard practice in modern pharmaceutical production lines. Moreover, the capability to gather and analyze data from the inspection process is providing companies with valuable insights that can be used to optimize production methods and enhance product quality.

X-ray Inspection Systems:

X-ray inspection systems are gaining traction in the pharmaceutical industry due to their ability to detect foreign objects and ensure the integrity of packaging. These systems employ X-ray technology to identify defects that are not visible to the naked eye, making them invaluable for ensuring quality control in drug manufacturing. The increasing complexity of pharmaceutical products and packaging further necessitates the use of X-ray systems to safeguard against contamination and defects that could compromise product safety. Furthermore, regulatory bodies are increasingly mandating the use of advanced inspection technologies, making X-ray inspection systems a critical component of the pharmaceutical quality assurance process. Their ability to perform thorough inspections with minimal disruption to production lines is also enhancing their appeal among manufacturers.

Optical Inspection Systems:

Optical inspection systems are a foundational technology in the pharmaceutical inspection market, utilizing light-based technologies to detect surface defects in products such as vials and tablets. These systems can effectively identify issues such as scratches, cracks, and discoloration that may affect product quality. Due to their versatility, optical inspection systems are widely utilized in various stages of pharmaceutical manufacturing, from drug production to packaging. The rising demand for high-quality pharmaceuticals, combined with stringent regulatory standards, is driving the adoption of optical inspection systems as manufacturers seek to minimize defects and ensure compliance. Moreover, advancements in optical technologies have led to the development of high-resolution systems capable of detecting even the slightest variations in product appearance, further enhancing quality control efforts.

Infrared Inspection Systems:

Infrared inspection systems are emerging as a critical technology in the pharmaceutical inspection market, particularly for assessing the integrity of products and packaging. These systems utilize infrared spectroscopy to analyze substances and detect impurities or contamination that may not be visible through traditional inspection methods. The ability to perform non-destructive testing makes infrared inspection systems particularly appealing in the pharmaceutical industry, where product integrity is paramount. Additionally, as the focus on drug quality increases and regulations become more stringent, the demand for sophisticated inspection technologies like infrared systems is expected to rise. Their capacity to provide rapid, accurate assessments contributes to improved production efficiency and enhanced safety, making them a valuable asset in pharmaceutical manufacturing.

Ultrasonic Inspection Systems:

Ultrasonic inspection systems are increasingly being recognized for their capability to detect internal defects in pharmaceutical products, such as vials and syringes. By using high-frequency sound waves, these systems can identify issues such as cracks and voids within solid materials, which are often undetectable through visual inspection. The application of ultrasonic technology in pharmaceutical inspections is particularly valuable for ensuring the quality of injectable products, where the integrity of the packaging is crucial. Additionally, as the market for complex drug formulations expands, the necessity for advanced inspection methods that ensure product safety and compliance with regulatory standards has grown. Ultrasonic inspection systems are thus becoming an integral part of quality assurance protocols in pharmaceutical manufacturing.

By Region

North America is expected to dominate the pharmaceutical equipment market for vial and tablet inspection, accounting for approximately 35% of the total market share. The region’s robust healthcare infrastructure, combined with high investments in pharmaceutical R&D, fosters a favorable environment for the growth of pharmaceutical inspection equipment. The presence of major pharmaceutical companies and stringent regulatory requirements further enhance the demand for advanced inspection machines. The market in North America is projected to grow at a CAGR of 6.5% from 2025 to 2035, driven by innovations in inspection technology and the increasing focus on drug safety and quality assurance.

Europe follows closely behind, representing around 30% of the global market share. The European market is characterized by strict regulatory frameworks, such as the European Medicines Agency (EMA) guidelines, which mandate rigorous inspection processes to ensure pharmaceutical safety. The growing emphasis on biopharmaceuticals and the increasing number of startups in the pharmaceutical sector contribute to the expansion of the inspection equipment market in this region. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, with an anticipated CAGR of 8.5%. The rapid expansion of pharmaceutical manufacturing in countries like China and India, coupled with rising healthcare expenditures, is driving the demand for advanced inspection technologies.

Opportunities

The pharmaceutical equipment market for vial and tablet inspection presents numerous opportunities for growth and innovation. One of the most significant opportunities lies in the integration of artificial intelligence (AI) and machine learning technologies into inspection processes. These advancements can enhance the accuracy of defect detection and streamline operations, reducing the need for manual inspections. As pharmaceutical companies focus on operational efficiency and cost reduction, AI-driven inspection solutions can provide the necessary tools to optimize production while ensuring compliance with regulatory standards. Moreover, the growing trend of personalized medicine presents a unique opportunity for manufacturers to develop specialized inspection equipment capable of handling diverse product formulations and varying batch sizes, thereby catering to the evolving needs of the market.

Another area of opportunity is the increasing demand for biologics and biosimilars, which require specialized inspection solutions to address their unique characteristics. The rising prevalence of chronic diseases has led to a surge in the development of injectable medications, creating a pressing need for reliable inspection technologies. Companies that can innovate and adapt their inspection equipment to accommodate these complex drug forms will likely gain a competitive edge in the market. Additionally, as emerging economies invest in modernizing their pharmaceutical manufacturing capabilities, global players in the inspection equipment market have a substantial opportunity to expand their reach and establish a foothold in these lucrative markets, contributing to overall industry growth.

Threats

Despite the promising outlook for the pharmaceutical equipment market, several threats could hinder its growth. One of the most pressing threats is the rapid pace of technological changes, which necessitate continuous investments in advanced machinery and inspection systems. Companies that fail to keep up with these advancements may find themselves at a competitive disadvantage, risking market share to more innovative competitors. Additionally, stringent regulatory requirements can pose a challenge for pharmaceutical manufacturers, as the cost of compliance can be burdensome, particularly for smaller companies. Any non-compliance incidents can lead to significant financial penalties and damage to brand reputation, further complicating market dynamics.

Another potential threat to the market is the increasing focus on sustainability and eco-friendly practices within the pharmaceutical industry. As regulatory bodies and consumers demand more sustainable production methods, manufacturers may face pressure to invest in inspection technologies that minimize waste and energy consumption. This shift could require considerable changes to existing processes and technologies, possibly leading to higher operational costs. Furthermore, economic uncertainties and geopolitical tensions can impact the global supply chain, causing disruptions in the procurement of inspection equipment and components, which may ultimately affect the overall market growth.

Competitor Outlook

• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Siemens Healthineers
• ABB Ltd.
• Rockwell Automation
• Körber AG
• Optel Group
• Becton, Dickinson and Company
• Schreiner Group GmbH
• Antares Vision S.p.A.
• Brevetti Stendalto S.r.l.
• Mettler-Toledo International Inc.
• QCR Solutions, LLC
• Festo AG & Co. KG

The competitive landscape of the pharmaceutical equipment market for vial and tablet inspection is characterized by the presence of several key players who are continually innovating and expanding their product offerings. Companies such as Thermo Fisher Scientific Inc. and GE Healthcare lead the market with their extensive portfolios and strong technological capabilities. These firms are heavily investing in R&D to develop advanced inspection solutions that cater to the evolving needs of the pharmaceutical industry. Moreover, strategic partnerships and collaborations are common in this market, allowing companies to leverage each other's expertise and resources to enhance their technological capabilities and market reach.

Another notable player, Sartorius AG, is recognized for its commitment to quality and innovation in laboratory and process technology. The company’s focus on automation solutions for the pharmaceutical sector enables it to offer cutting-edge inspection equipment that improves accuracy and efficiency. Furthermore, companies like Antares Vision S.p.A. and Körber AG are emerging as significant players in the market. They specialize in providing integrated inspection solutions that enhance product quality and comply with regulatory standards, establishing themselves as trusted partners for pharmaceutical manufacturers.

As competition intensifies, practitioners in the pharmaceutical equipment market are adopting various strategies to differentiate themselves. This includes developing specialized products tailored for specific applications, expanding into emerging markets, and enhancing customer service capabilities. Companies are also focusing on sustainability and eco-friendly practices to align with the growing demand for greener processes in the pharmaceutical industry. The ability to innovate and respond to market demands will ultimately determine the success of these players in the rapidly evolving pharmaceutical equipment market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ABB Ltd.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Optel Group
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sartorius AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Körber AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Festo AG & Co. KG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 QCR Solutions, LLC
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Rockwell Automation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Schreiner Group GmbH
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Siemens Healthineers
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Antares Vision S.p.A.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Brevetti Stendalto S.r.l.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Becton, Dickinson and Company
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Mettler-Toledo International Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Equipment for Vial and Tablet Inspection Market, By User
    • 6.1.1 Pharmaceutical Companies
    • 6.1.2 Contract Research Organizations
  • 6.2 Pharmaceutical Equipment for Vial and Tablet Inspection Market, By Technology
    • 6.2.1 Machine Vision Systems
    • 6.2.2 X-ray Inspection Systems
    • 6.2.3 Optical Inspection Systems
    • 6.2.4 Infrared Inspection Systems
    • 6.2.5 Ultrasonic Inspection Systems
  • 6.3 Pharmaceutical Equipment for Vial and Tablet Inspection Market, By Application
    • 6.3.1 Drug Manufacturing
    • 6.3.2 Research Laboratories
    • 6.3.3 Packaging
  • 6.4 Pharmaceutical Equipment for Vial and Tablet Inspection Market, By Product Type
    • 6.4.1 Vial Inspection Machines
    • 6.4.2 Tablet Inspection Machines
    • 6.4.3 Ampoule Inspection Machines
    • 6.4.4 Syringe Inspection Machines
    • 6.4.5 Capsule Inspection Machines

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Equipment for Vial and Tablet Inspection Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Equipment for Vial and Tablet Inspection market is categorized based on

By Product Type

• Vial Inspection Machines
• Tablet Inspection Machines
• Ampoule Inspection Machines
• Syringe Inspection Machines
• Capsule Inspection Machines

By Application

• Drug Manufacturing
• Research Laboratories
• Packaging

By User

• Pharmaceutical Companies
• Contract Research Organizations

By Technology

• Machine Vision Systems
• X-ray Inspection Systems
• Optical Inspection Systems
• Infrared Inspection Systems
• Ultrasonic Inspection Systems

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Siemens Healthineers
• ABB Ltd.
• Rockwell Automation
• Körber AG
• Optel Group
• Becton, Dickinson and Company
• Schreiner Group GmbH
• Antares Vision S.p.A.
• Brevetti Stendalto S.r.l.
• Mettler-Toledo International Inc.
• QCR Solutions, LLC
• Festo AG & Co. KG